Literature DB >> 17041806

[Sex-specific antihypertensive drug therapy].

Petra Pühringer1, Ghazaleh Gouya, Berthold Reichardt, Michael Wolzt.   

Abstract

BACKGROUND: Hypertension is a leading cause of cardiovascular diseases. To evaluate sex-specific differences in the prescription pattern of antihypertensive therapy, registry data from the regional health insurance fund "Burgenländische Gebietskrankenkasse" (BGKK) were analyzed.
MATERIAL AND METHODS: In a retrospective cross sectional cohort study data from 41499 individuals covered by the BGKK in 2003, and who had been treated with cardiovascular drugs were analyzed. Data were evaluated according to drug classifications.
RESULTS: Among subjects treated with cardiovascular medication 38.3 % were males and 61.7 % females. The drug classes acting on the renin-angiotensin-system were prescribed more frequently than beta-blockers, calcium channel blockers, diuretics and antihypertensives. Women were treated more often with diuretics and beta-blockers, whereas men received more antihypertensives and drugs acting on the renin angiotensin system (p < 0.01 between groups of sexes).
CONCLUSION: Sex-specific differences exist regarding the prevalence of antihypertensive drug prescriptions between men and women. Further, the prescription pattern of equivalently effective medications differs between sexes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041806     DOI: 10.1007/s10354-006-0334-1

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  6 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

Review 2.  Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.

Authors:  Jan A Staessen; Yan Li; Lutgarde Thijs; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2005-05       Impact factor: 3.872

3.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

Review 4.  Hypertension in women.

Authors:  P August; S Oparil
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

5.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

6.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.